Search

Health Secretary Robert F. Kennedy Jr. announced initiatives to encourage individuals to reconsider the use of antidepressants, particularly S.S.R.I.s, while experts emphasize that the decision to stop should be made collaboratively with a healthcare provider, taking into account individual recovery, potential withdrawal symptoms, and the risks of relapse, with a general recommendation to taper off the medication gradually and safely. #MentalHealth #Antidepressants #Deprescribing #US #GB

Health Secretary Robert F. Kennedy Jr. has announced initiatives aimed at reducing the overprescription of selective serotonin reuptake inhibitors (SSRIs) in the U.S., promoting nonpharmaceutical interventions and enhancing support for patients seeking to discontinue these psychiatric medications, amidst ongoing debates about their accessibility and the nuances of withdrawal symptoms. #MentalHealth #PsychiatricMedication #Deprescribing #US #GB #DE

Health Secretary Robert F. Kennedy Jr. announced new initiatives aimed at reducing the prescription of psychiatric medications, particularly selective serotonin reuptake inhibitors (SSRIs), by encouraging clinicians to consider alternative treatments and support patients in tapering off these medications, while acknowledging ongoing debates about the appropriate balance of prescribing practices in mental health care. #MentalHealth #Psychiatry #Deprescribing #US #GB #DE

Health Secretary Robert F. Kennedy Jr. has announced new initiatives aimed at reducing the prescription of selective serotonin reuptake inhibitors (SSRIs) in response to concerns about overuse and withdrawal difficulties, emphasizing a shift towards nonpharmaceutical interventions and ensuring patients have better support in managing their mental health treatment. #MentalHealth #Psychiatry #Deprescribing #US #GB #DE

Health Secretary Robert F. Kennedy Jr. announced new initiatives aimed at reducing the overprescription of selective serotonin reuptake inhibitors, emphasizing the importance of exploring nonpharmaceutical treatments and providing support for patients seeking to discontinue psychiatric medications, amidst concerns about withdrawal symptoms and the overall reliance on such drugs. #MentalHealth #Psychiatry #Deprescribing #US #GB #DE

The article discusses the issue of polypharmacy in elderly patients, particularly focusing on a patient with advanced cancer who was prescribed an overwhelming number of medications, leading to confusion and potential harm; it advocates for de-prescribing, a process to safely reduce unnecessary medications, and emphasizes the importance of communication between healthcare providers and patients to enhance quality of life for older individuals. #DePrescribing #Polypharmacy #ElderCare